Europe Ophthalmic Drugs Market Report 2016

November 2016 | 129 pages | ID: E9CDDD7589DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Ophthalmic Drugs

Revenue, means the sales value of Ophthalmic Drugs

This report studies sales (consumption) of Ophthalmic Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Novartis
• Santen Pharmaceutical
• Merck
• Roche Holding AG
• Pfizer
• Allergan
• Valeant
• Regeneron
• Bayer
• Senju
• Akorn

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Ophthalmic Drugs in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Prescription Drugs
• OTC Drugs
• Type III

Split by application, this report focuses on sales, market share and growth rate of Ophthalmic Drugs in each application, can be divided into

• Dry Eye Drugs
• Retinal Drugs
• Anti-inflammatory/allergy/infective Drugs
• Anti-glaucoma Drugs
• Others

Contents

Europe Ophthalmic Drugs Market Report 2016

1 OPHTHALMIC DRUGS OVERVIEW

1.1 Product Overview and Scope of Ophthalmic Drugs
1.2 Classification of Ophthalmic Drugs
  1.2.1 Prescription Drugs
  1.2.2 OTC Drugs
  1.2.3 Type III
1.3 Application of Ophthalmic Drugs
  1.3.1 Dry Eye Drugs
  1.3.2 Retinal Drugs
  1.3.3 Anti-inflammatory/allergy/infective Drugs
  1.3.4 Anti-glaucoma Drugs
  1.3.5 Others
1.4 Ophthalmic Drugs Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Ophthalmic Drugs (2011-2021)
  1.5.1 Europe Ophthalmic Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Europe Ophthalmic Drugs Revenue and Growth Rate (2011-2021)

2 EUROPE OPHTHALMIC DRUGS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Ophthalmic Drugs Market Competition by Manufacturers
  2.1.1 Europe Ophthalmic Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Ophthalmic Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Ophthalmic Drugs (Volume and Value) by Type
  2.2.1 Europe Ophthalmic Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Ophthalmic Drugs Revenue and Market Share by Type (2011-2016)
2.3 Europe Ophthalmic Drugs (Volume and Value) by Countries
  2.3.1 Europe Ophthalmic Drugs Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Ophthalmic Drugs Revenue and Market Share by Countries (2011-2016)
2.4 Europe Ophthalmic Drugs (Volume) by Application

3 GERMANY OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Ophthalmic Drugs Sales and Value (2011-2016)
  3.1.1 Germany Ophthalmic Drugs Sales and Growth Rate (2011-2016)
  3.1.2 Germany Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Ophthalmic Drugs Sales Price Trend (2011-2016)
3.2 Germany Ophthalmic Drugs Sales and Market Share by Manufacturers
3.3 Germany Ophthalmic Drugs Sales and Market Share by Type
3.4 Germany Ophthalmic Drugs Sales and Market Share by Application

4 FRANCE OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 France Ophthalmic Drugs Sales and Value (2011-2016)
  4.1.1 France Ophthalmic Drugs Sales and Growth Rate (2011-2016)
  4.1.2 France Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
  4.1.4 France Ophthalmic Drugs Sales Price Trend (2011-2016)
4.2 France Ophthalmic Drugs Sales and Market Share by Manufacturers
4.3 France Ophthalmic Drugs Sales and Market Share by Type
4.4 France Ophthalmic Drugs Sales and Market Share by Application

5 UK OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Ophthalmic Drugs Sales and Value (2011-2016)
  5.1.1 UK Ophthalmic Drugs Sales and Growth Rate (2011-2016)
  5.1.2 UK Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
  5.1.5 UK Ophthalmic Drugs Sales Price Trend (2011-2016)
5.2 UK Ophthalmic Drugs Sales and Market Share by Manufacturers
5.3 UK Ophthalmic Drugs Sales and Market Share by Type
5.4 UK Ophthalmic Drugs Sales and Market Share by Application

6 RUSSIA OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Ophthalmic Drugs Sales and Value (2011-2016)
  6.1.1 Russia Ophthalmic Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Russia Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Ophthalmic Drugs Sales Price Trend (2011-2016)
6.2 Russia Ophthalmic Drugs Sales and Market Share by Manufacturers
6.3 Russia Ophthalmic Drugs Sales and Market Share by Type
6.4 Russia Ophthalmic Drugs Sales and Market Share by Application

7 ITALY OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Ophthalmic Drugs Sales and Value (2011-2016)
  7.1.1 Italy Ophthalmic Drugs Sales and Growth Rate (2011-2016)
  7.1.2 Italy Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Ophthalmic Drugs Sales Price Trend (2011-2016)
7.2 Italy Ophthalmic Drugs Sales and Market Share by Manufacturers
7.3 Italy Ophthalmic Drugs Sales and Market Share by Type
7.4 Italy Ophthalmic Drugs Sales and Market Share by Application

8 SPAIN OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Ophthalmic Drugs Sales and Value (2011-2016)
  8.1.1 Spain Ophthalmic Drugs Sales and Growth Rate (2011-2016)
  8.1.2 Spain Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Ophthalmic Drugs Sales Price Trend (2011-2016)
8.2 Spain Ophthalmic Drugs Sales and Market Share by Manufacturers
8.3 Spain Ophthalmic Drugs Sales and Market Share by Type
8.4 Spain Ophthalmic Drugs Sales and Market Share by Application

9 BENELUX OPHTHALMIC DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Ophthalmic Drugs Sales and Value (2011-2016)
  9.1.1 Benelux Ophthalmic Drugs Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Ophthalmic Drugs Sales Price Trend (2011-2016)
9.2 Benelux Ophthalmic Drugs Sales and Market Share by Manufacturers
9.3 Benelux Ophthalmic Drugs Sales and Market Share by Type
9.4 Benelux Ophthalmic Drugs Sales and Market Share by Application

10 EUROPE OPHTHALMIC DRUGS MANUFACTURERS ANALYSIS

10.1 Novartis
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Ophthalmic Drugs Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Novartis Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Santen Pharmaceutical
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Ophthalmic Drugs Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Santen Pharmaceutical Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Merck
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Ophthalmic Drugs Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Merck Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Roche Holding AG
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Ophthalmic Drugs Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Roche Holding AG Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Pfizer
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Ophthalmic Drugs Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Pfizer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Allergan
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Ophthalmic Drugs Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Allergan Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Valeant
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Ophthalmic Drugs Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Valeant Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Regeneron
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Ophthalmic Drugs Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Regeneron Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Bayer
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Ophthalmic Drugs Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Bayer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Senju
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Ophthalmic Drugs Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Senju Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Akorn

11 OPHTHALMIC DRUGS MANUFACTURING COST ANALYSIS

11.1 Ophthalmic Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Ophthalmic Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Ophthalmic Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Ophthalmic Drugs Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE OPHTHALMIC DRUGS MARKET FORECAST (2016-2021)

14.1 Germany Ophthalmic Drugs Sales Forecast (2016-2021)
14.2 France Ophthalmic Drugs Sales Forecast (2016-2021)
14.3 UK Ophthalmic Drugs Sales Forecast (2016-2021)
14.4 Russia Ophthalmic Drugs Sales Forecast (2016-2021)
14.5 Italy Ophthalmic Drugs Sales Forecast (2016-2021)
14.6 Spain Ophthalmic Drugs Sales Forecast (2016-2021)
14.7 Benelux Ophthalmic Drugs Sales Forecast (2016-2021)
14.8 Europe Ophthalmic Drugs Sales Forecast by Type (2016-2021)
14.9 Europe Ophthalmic Drugs Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ophthalmic Drugs
Table Classification of Ophthalmic Drugs
Figure Europe Sales Market Share of Ophthalmic Drugs by Type in 2015
Figure Prescription Drugs Picture
Figure OTC Drugs Picture
Table Application of Ophthalmic Drugs
Figure Europe Sales Market Share of Ophthalmic Drugs by Application in 2015
Figure Dry Eye Drugs Examples
Figure Retinal Drugs Examples
Figure Anti-inflammatory/allergy/infective Drugs Examples
Figure Anti-glaucoma Drugs Examples
Figure Others Examples
Figure Germany Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Figure France Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Figure UK Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Figure Benelux Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
2
Figure Europe Ophthalmic Drugs Revenue and Growth Rate (2011-2021)
Table Europe Ophthalmic Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Ophthalmic Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ophthalmic Drugs Sales Share by Manufacturers
Figure 2016 Ophthalmic Drugs Sales Share by Manufacturers
Table Europe Ophthalmic Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Ophthalmic Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Ophthalmic Drugs Revenue Share by Manufacturers
Table 2016 Europe Ophthalmic Drugs Revenue Share by Manufacturers
Table Europe Ophthalmic Drugs Sales and Market Share by Type (2011-2016)
Table Europe Ophthalmic Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Ophthalmic Drugs by Type (2011-2016)
Figure Europe Ophthalmic Drugs Sales Growth Rate by Type (2011-2016)
Table Europe Ophthalmic Drugs Revenue and Market Share by Type (2011-2016)
Table Europe Ophthalmic Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Ophthalmic Drugs by Type (2011-2016)
Figure Europe Ophthalmic Drugs Revenue Growth Rate by Type (2011-2016)
Table Europe Ophthalmic Drugs Sales and Market Share by Countries (2011-2016)
Table Europe Ophthalmic Drugs Sales Share by Countries (2011-2016)
Figure Sales Market Share of Ophthalmic Drugs by Countries (2011-2016)
Table Europe Ophthalmic Drugs Revenue and Market Share by Countries (2011-2016)
Table Europe Ophthalmic Drugs Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Ophthalmic Drugs by Countries (2011-2016)
Table Europe Ophthalmic Drugs Sales and Market Share by Application (2011-2016)
Table Europe Ophthalmic Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Ophthalmic Drugs by Application (2011-2016)
Figure Germany Ophthalmic Drugs Sales and Growth Rate (2011-2016)
Figure Germany Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
Figure Germany Ophthalmic Drugs Sales Price Trend (2011-2016)
Table Germany Ophthalmic Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Ophthalmic Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Ophthalmic Drugs Sales by Type (2015 and 2016)
Table Germany Ophthalmic Drugs Market Share by Type (2015 and 2016)
Table Germany Ophthalmic Drugs Sales by Application (2015 and 2016)
Table Germany Ophthalmic Drugs Market Share by Application (2015 and 2016)
Figure France Ophthalmic Drugs Sales and Growth Rate (2011-2016)
Figure France Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
Figure France Ophthalmic Drugs Sales Price Trend (2011-2016)
Table France Ophthalmic Drugs Sales by Manufacturers (2015 and 2016)
Table France Ophthalmic Drugs Market Share by Manufacturers (2015 and 2016)
Table France Ophthalmic Drugs Sales by Type (2015 and 2016)
Table France Ophthalmic Drugs Market Share by Type (2015 and 2016)
Table France Ophthalmic Drugs Sales by Application (2015 and 2016)
Table France Ophthalmic Drugs Market Share by Application (2015 and 2016)
Figure UK Ophthalmic Drugs Sales and Growth Rate (2011-2016)
Figure UK Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
Figure UK Ophthalmic Drugs Sales Price Trend (2011-2016)
Table UK Ophthalmic Drugs Sales by Manufacturers (2015 and 2016)
Table UK Ophthalmic Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Ophthalmic Drugs Sales by Type (2015 and 2016)
Table UK Ophthalmic Drugs Market Share by Type (2015 and 2016)
Table UK Ophthalmic Drugs Sales by Application (2015 and 2016)
Table UK Ophthalmic Drugs Market Share by Application (2015 and 2016)
Figure Russia Ophthalmic Drugs Sales and Growth Rate (2011-2016)
Figure Russia Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
Figure Russia Ophthalmic Drugs Sales Price Trend (2011-2016)
Table Russia Ophthalmic Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Ophthalmic Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Ophthalmic Drugs Sales by Type (2015 and 2016)
Table Russia Ophthalmic Drugs Market Share by Type (2015 and 2016)
Table Russia Ophthalmic Drugs Sales by Application (2015 and 2016)
Table Russia Ophthalmic Drugs Market Share by Application (2015 and 2016)
Figure Italy Ophthalmic Drugs Sales and Growth Rate (2011-2016)
Figure Italy Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
Figure Italy Ophthalmic Drugs Sales Price Trend (2011-2016)
Table Italy Ophthalmic Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Ophthalmic Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Ophthalmic Drugs Sales by Type (2015 and 2016)
Table Italy Ophthalmic Drugs Market Share by Type (2015 and 2016)
Table Italy Ophthalmic Drugs Sales by Application (2015 and 2016)
Table Italy Ophthalmic Drugs Market Share by Application (2015 and 2016)
Figure Spain Ophthalmic Drugs Sales and Growth Rate (2011-2016)
Figure Spain Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
Figure Spain Ophthalmic Drugs Sales Price Trend (2011-2016)
Table Spain Ophthalmic Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Ophthalmic Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Ophthalmic Drugs Sales by Type (2015 and 2016)
Table Spain Ophthalmic Drugs Market Share by Type (2015 and 2016)
Table Spain Ophthalmic Drugs Sales by Application (2015 and 2016)
Table Spain Ophthalmic Drugs Market Share by Application (2015 and 2016)
Figure Benelux Ophthalmic Drugs Sales and Growth Rate (2011-2016)
Figure Benelux Ophthalmic Drugs Revenue and Growth Rate (2011-2016)
Figure Benelux Ophthalmic Drugs Sales Price Trend (2011-2016)
Table Benelux Ophthalmic Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Ophthalmic Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Ophthalmic Drugs Sales by Type (2015 and 2016)
Table Benelux Ophthalmic Drugs Market Share by Type (2015 and 2016)
Table Benelux Ophthalmic Drugs Sales by Application (2015 and 2016)
Table Benelux Ophthalmic Drugs Market Share by Application (2015 and 2016)
Table Ophthalmic Drugs Basic Information List
Table Novartis Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Ophthalmic Drugs Sales Market Share (2011-2016)
Table Santen Pharmaceutical Basic Information List
Table Santen Pharmaceutical Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Santen Pharmaceutical Ophthalmic Drugs Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Ophthalmic Drugs Sales Market Share (2011-2016)
Table Roche Holding AG Basic Information List
Table Roche Holding AG Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Holding AG Ophthalmic Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Ophthalmic Drugs Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Ophthalmic Drugs Sales Market Share (2011-2016)
Table Valeant Basic Information List
Table Valeant Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Ophthalmic Drugs Sales Market Share (2011-2016)
Table Regeneron Basic Information List
Table Regeneron Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Regeneron Ophthalmic Drugs Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Ophthalmic Drugs Sales Market Share (2011-2016)
Table Senju Basic Information List
Table Senju Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Senju Ophthalmic Drugs Sales Market Share (2011-2016)
Table Akorn Basic Information List
Table Akorn Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Akorn Ophthalmic Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ophthalmic Drugs
Figure Manufacturing Process Analysis of Ophthalmic Drugs
Figure Ophthalmic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ophthalmic Drugs Major Manufacturers in 2015
Table Major Buyers of Ophthalmic Drugs
Table Distributors/Traders List
Figure Germany Ophthalmic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Germany Ophthalmic Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure France Ophthalmic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure France Ophthalmic Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure UK Ophthalmic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure UK Ophthalmic Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Ophthalmic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Russia Ophthalmic Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Ophthalmic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Italy Ophthalmic Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Ophthalmic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Spain Ophthalmic Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Ophthalmic Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Ophthalmic Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Europe Ophthalmic Drugs Sales Forecast by Type (2016-2021)
Table Europe Ophthalmic Drugs Sales Forecast by Application (2016-2021)